Elsevier

Brain Research

Volume 193, Issue 1, 7 July 1980, Pages 95-115
Brain Research

Alpha-adrenoceptive influences on the control of the sleep-waking cycle in the cat

https://doi.org/10.1016/0006-8993(80)90948-8Get rights and content

Abstract

Polygraphic 16 h sleep recordings were carried out in 35 adult cats following i.p. injections of various α-adrenoceptor agonists, antagonists and their combinations.

The direct α-agonists, clonidine (CLO 0.005, 0.01 and 0.02 mg/kg) and xylazine (XYL 0.5, 1 and 2 mg/kg), dose-dependently decreased paradoxical sleep (PS) and deep slow wave sleep (S2), with a respective increase mainly in drowsy waking (D). α-Methyldopa, precursor of the potent α-agonist, α-m-noradrenaline (α-m-NA) suppressed PS, with little effect on other vigilance stages.

Of the α-antagonists only phentolamine (PHE 10 and 20 mg/kg) increased significantly the 16 h mean of PS. Thymoxamine (THY 5 mg/kg) gave a modest, temporary increment in PS between 4 and 8 h after the injection, but the effect diminished with 10 mg/kg THY. Yohimbine (YOH 2 mg/kg) induced an early increment in aroused waking (A). Tolazoline (TOL 6 mg/kg) and THY (5 and 10 mg/kg) increased D in the first 4 h epoch. Phenoxybenzamine (PBZ 10 mg/kg) significantly decreased the 16 h mean of S2 and PS.

PHE antagonized the PS suppressing effect of CLO (0.01 mg/kg) already at the dose of 5 mg/kg and with 10 and 20 mg/kg its PS increasing character prevailed. TOL (6 mg/kg) and YOH (2 mg/kg) were also effective antagonists to CLO. THY (5 and 10 mg/kg) was ineffective in this respect and clearly potentiated the S2 inhibiting effect of CLO. PBZ (10 mg/kg) powerfully potentiated both PS and S2 suppressing effects of CLO.

PHE (20 mg/kg) was tested against XYL (0.5 and 1 mg/kg) and α-methyldopa (100 mg/kg). It also antagonized the PS inhibiting action of these drugs.

All the three agonists preferentially stimulate presynaptic (α2) type of α-adrenoceptors, inhibitory to noradrenaline (NA) transmission. Furthermore, as only antagonists possessing presynaptic potency inhibited PS suppression byα2-agonists, while preferentialα1-antagonists were either ineffective or potentiated this effect, the results favor the hypothesis of a positive involvement of NA in the mechenism of PS. The optimal level of NA transmission for PS may, however, be postulated to lie below that for arousal, in which case the balanced blockade ofα1-andα2-adrenoceptors by PHE might be exceptionally favorable to PS.

The possible role of α-adrenoceptive influences on cholinergic and 5-HT neurons and their relevance toα2-agonist-induced sedation and inhibition of PS and S2 are discussed.

Reference (71)

  • KleinlogelH. et al.

    Effects of clonidine and BS 100–141 on the EEG sleep patterns in rats

    Europ. J. Pharmacol.

    (1975)
  • LambertG.A. et al.

    Pharmacological and biochemical properties of isomeric yohimbine alkaloids

    Europ. J. Pharmacol.

    (1978)
  • LangerS.Z.

    Presynaptic adrenoceptors and regulation of release

  • LeppävuoriA. et al.

    Evidence for central alpha-adrenoceptor stimulation as the basis of paradoxical sleep suppression by alpha methyldopa

    Neurosci. Lett.

    (1978)
  • LeppävuoriA.

    The effects of an alpha-adrenergic agonist or antagonist on sleep during blockade of catecholamine synthesis in the cat

    Brain Research

    (1980)
  • PapeschiR. et al.

    The effect of yohimbine on the turnover of brain catecholamines and serotonin

    Europ. J. Pharmacol.

    (1975)
  • PickworthW.B. et al.

    Sleep suppression induced by intravenous and intraventricular infusions of methoxamine in the dog

    Exp. Neurol.

    (1977)
  • SheuY.-S. et al.

    Discharge patterns of cat raphe neurons during sleep and waking

    Brain Research

    (1974)
  • StarkeK.

    Presynaptic regulation of release in the central nervous system

  • StermanM.B. et al.

    Circadian sleep and waking patterns in the laboratory cat

    Electroenceph. clin. Neurophysiol.

    (1965)
  • SternW.C. et al.

    Theoretical view of REM sleep function: maintenance of catecholamine systems in the central nervous system

    Behav. Biol.

    (1974)
  • SvenssonT.H. et al.

    Inhibition of both noradrenergic and serotonergic neurons in brain by the α-adrenergic agonist clonidine

    Brain Research

    (1975)
  • TrulsonM.E. et al.

    Raphe unit activity in freely moving cats: correlation with level of behavioral arousal

    Brain Research

    (1979)
  • UrsinR.

    The two stages of slow wave sleep in the cat and their relation to REM sleep

    Brain Research

    (1968)
  • AghajanianG.K. et al.

    Physiology and pharmacology of central serotonergic neurons

  • AndénN.-E. et al.

    Different alpha-adrenoceptors in central nervous system mediating biochemical and functional effects of clonidine and receptor blocking agents

    Naunyn-Schmiedeberg's Arch. exp. Path. Pharmak.

    (1976)
  • AutretA. et al.

    Effect of clonidine on sleep patterns in man

    Europ. J. clin. Pharmacol.

    (1977)
  • BerthelsonS. et al.

    A functional basis for classification of α-adrenergic receptors

    Life Sci.

    (1977)
  • Bevan, P., Bradshaw, C. M. and Szabadi, E. The pharmacology of adrenergic neuronal responses in the cerebral cortex:...
  • BirminghamA.T. et al.

    Competitive blockade of adrenergic α-receptors and histamine receptors by thymoxamine

    J. Pharm. Pharmacol.

    (1965)
  • CaveroI. et al.

    Time-course analysis of the cardiovascular effects of clonidine resulting from the activation of cardiac pre- and vascular postsynaptic α-adrenoceptors in the pithed rat

    Brit. J. Pharmacol.

    (1978)
  • ChuN.-S. et al.

    Activity patterns of catecholamine-containing pontine neurons in the dorso-lateral tegmentum of unrestrained cats

    J. Neurobiol.

    (1974)
  • CollierJ.G. et al.

    Comparison of blockade at α-adrenoceptors by thymoxamine and phentolamine in peripheral arteries and veins of man

    Brit. J. Pharmacol.

    (1972)
  • CubedduL. et al.

    Release of norepinephrine and dopamine-ß-hydroxylase by nerve stimulation. I. Role of neuronal and extraneuronal uptake and of alpha presynaptic receptors

    J. Pharmacol. exp. Ther.

    (1974)
  • DepoortereH.

    Effects of some pre- and post-synaptic noradrenergic antagonists on the central action of clonidine

  • Cited by (0)

    View full text